NEOGENOMICS INC (NEO)
SEC fundamentals · as filed in 10-Q FY2026, period ended Sep 30, 2026 · updated Oct 30, 2026
as filed in 10-Q FY2026, period ended Sep 30, 2026 · View filings on EDGAR ↗
In its 10-Q for the period ended Sep 30, 2026, NEOGENOMICS INC reported revenue of $209.3M, net income of -$7.5M, and total assets of $1.38B. Every figure below is taken directly from NEOGENOMICS INC's SEC filings: each links to the source document on EDGAR.
Revenue trend
Revenue · FY2016–FY2025 · as reported
- FY2016 revenue
- $231.8M
- FY2025 revenue
- $727.3M
Revenue and net income by fiscal year
As reported in each year’s annual filing · USD
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY2025 | $727.3M | -$108.0M |
| FY2024 | $660.6M | -$78.7M |
| FY2023 | $591.6M | -$88.0M |
| FY2022 | $509.7M | -$144.3M |
| FY2021 | $484.3M | -$8.3M |
| FY2020 | $444.4M | $4.2M |
| FY2019 | $408.8M | $8.0M |
| FY2018 | $276.7M | $2.6M |
| FY2017 | $240.3M | -$396,000 |
| FY2016 | $231.8M | -$6.1M |
Recent SEC filings
Filed by the registrant · newest first · insider forms and holder schedules not included
| Form | Filed | Source |
|---|---|---|
| 8-K | Oct 28, 2026 | on EDGAR ↗ |
| 10-Q | Oct 28, 2026 | on EDGAR ↗ |
| 8-K | Oct 5, 2026 | on EDGAR ↗ |
| 8-K | Aug 11, 2026 | on EDGAR ↗ |
| 8-K | Jul 28, 2026 | on EDGAR ↗ |
| 10-Q | Jul 28, 2026 | on EDGAR ↗ |
| 8-K | Jul 20, 2026 | on EDGAR ↗ |
| 8-K | Jun 25, 2026 | on EDGAR ↗ |
| 8-K | Jun 22, 2026 | on EDGAR ↗ |
| 8-K | Jun 17, 2026 | on EDGAR ↗ |
Balance Sheet
as of Sep 30, 2026 · 10-Q
Income Statement
10-Q (quarterly) · period ended Sep 30, 2026
| Revenue | $209.3M | Revenue | source ↗ |
| Net Income | -$7.5M | Net | source ↗ |
| Operating Income | -$7.9M | Operating | source ↗ |
| Gross Profit | $96.6M | Gross | source ↗ |
| Cost of Revenue | $112.7M | Cost | source ↗ |
| R&D Expense | $9.9M | Research | source ↗ |
Per Share & Cash Flow
10-Q (quarterly) · period ended Sep 30, 2026
| EPS (diluted) | — | — | source ↗ |
| EPS (basic) | — | — | source ↗ |
| Shares Outstanding | 129.4M | Entity | source ↗ |
| Cash from Operations | -$8.9M | Net | source ↗ |
| Cash from Financing | $14.5M | Net | source ↗ |
| Cash from Investing | -$11.8M | Net | source ↗ |
Insider activity
Form 4 open-market activity, last 180 days
- Buys
- 0
- Sells
- 3
- Net shares
- -30.6K
Restatement history
Point-in-time20 of 494 annual fact-keys were materially restated between filings: what NEOGENOMICS INC first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.
See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.
Deeper fundamentals
A free API key reaches NEO’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- These fundamentals, as filed
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/NEO
MCP tool:
get_sec_fundamentals ticker=NEO - The same figures as they were known on any past date
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/NEO/as-of/YYYY-MM-DD
MCP tool:
get_asof_fundamentals ticker=NEO as_of=YYYY-MM-DD - Fiscal-year trajectory: revenue, margins, free cash flow
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/NEO/history
MCP tool:
get_fundamentals_history ticker=NEO - Leverage, liquidity, margin and return ratios
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/financial-health/NEO
MCP tool:
get_financial_health ticker=NEO
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.